From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia.

Taispeáin leaganacha eile (1)

BACKGROUND: Following the recognition that morbidity and mortality due to malaria had dramatically increased in the last three decades, in 2002 the government of Zambia reviewed its efforts to prevent and treat malaria. Convincing evidence of the failing efficacy of chloroquine resulted in the init...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Sipilanyambe, N, Simon, J, Chanda, P, Olumese, P, Snow, R, Hamer, D
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2008

Míreanna comhchosúla

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
de réir: Sipilanyambe, N, et al.
Foilsithe / Cruthaithe: (2008)

From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia
de réir: Snow Robert W, et al.
Foilsithe / Cruthaithe: (2008-01-01)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.
de réir: Zurovac, D, et al.
Foilsithe / Cruthaithe: (2007)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
de réir: Zurovac, D, et al.
Foilsithe / Cruthaithe: (2007)

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
de réir: Chanda Pascalina, et al.
Foilsithe / Cruthaithe: (2007-03-01)

A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
de réir: Hawela Moonga, et al.
Foilsithe / Cruthaithe: (2007-02-01)

Assessment of the therapeutic efficacy of a paediatric formulation of artemether-lumefantrine (Coartesiane<sup>®</sup>) for the treatment of uncomplicated <it>Plasmodium falciparum </it>in children in Zambia
de réir: Kango Mabvuto, et al.
Foilsithe / Cruthaithe: (2006-08-01)

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.
de réir: Zurovac, D, et al.
Foilsithe / Cruthaithe: (2005)

Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.
de réir: Zurovac, D, et al.
Foilsithe / Cruthaithe: (2008)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
de réir: Ssekitooleko James, et al.
Foilsithe / Cruthaithe: (2008-09-01)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.
de réir: Zurovac, D, et al.
Foilsithe / Cruthaithe: (2008)

Malaria case-management under artemether-lumefantrine treatment policy in Uganda
de réir: Zurovac, D, et al.
Foilsithe / Cruthaithe: (2008)

The use of artemether-lumefantrine by febrile children following national implementation of a revised drug policy in Kenya.
de réir: Gitonga, C, et al.
Foilsithe / Cruthaithe: (2008)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
de réir: White, N, et al.
Foilsithe / Cruthaithe: (1999)

Drug interactions between dolutegravir and artemether-lumefantrine or artesunate-amodiaquine
de réir: Walimbwa, S, et al.
Foilsithe / Cruthaithe: (2018)

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia
de réir: Manyando Christine, et al.
Foilsithe / Cruthaithe: (2010-09-01)

Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
de réir: Sileshi Belew, et al.
Foilsithe / Cruthaithe: (2020-04-01)

Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial
de réir: Abreha, T, et al.
Foilsithe / Cruthaithe: (2017)

Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
de réir: Tesfay Abreha, et al.
Foilsithe / Cruthaithe: (2017-05-01)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
de réir: White, N, et al.
Foilsithe / Cruthaithe: (1999)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine.
de réir: Ali, S, et al.
Foilsithe / Cruthaithe: (2010)

In vivo efficacy of artemether-lumefantrine and chloroquine against Plasmodium vivax: a randomized open label trial in central Ethiopia.
de réir: Jimee Hwang, et al.
Foilsithe / Cruthaithe: (2013-01-01)

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
de réir: van Vugt, M, et al.
Foilsithe / Cruthaithe: (1999)

Implementation of artemether-lumefantrine treatment policy for malaria at health facilities in Tanzania
de réir: Mugoyela V, et al.
Foilsithe / Cruthaithe: (2011-09-01)

DRUG-DRUG INTERACTIONS BETWEEN ARTEMETHER/LUMEFANTRINE AND LOPINAVIR/RITONAVIR IN HIV NEGATIVE HEALTHY VOLUNTEERS
de réir: German, P, et al.
Foilsithe / Cruthaithe: (2008)

Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
de réir: van Vugt, M, et al.
Foilsithe / Cruthaithe: (2000)

Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi malaria (CAN KNOW): an open-label randomized controlled trial
de réir: Grigg, M, et al.
Foilsithe / Cruthaithe: (2017)

Adverse Drug Event From Artemether/lumefantrine Ingestion: Case Series
de réir: Chinawa JM
Foilsithe / Cruthaithe: (2024-07-01)

Artemether-lumefantrine versus chloroquine for the treatment of uncomplicated Plasmodium knowlesi malaria : an open-label randomized controlled trial CAN KNOW
de réir: Grigg, Matthew J., et al.
Foilsithe / Cruthaithe: (2020)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
de réir: Tarning, J, et al.
Foilsithe / Cruthaithe: (2009)

Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
de réir: Tarning Joel, et al.
Foilsithe / Cruthaithe: (2010-10-01)

Correction: Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial.
de réir: Tesfay Abreha, et al.
Foilsithe / Cruthaithe: (2018-10-01)

Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
de réir: Ursing, J, et al.
Foilsithe / Cruthaithe: (2011)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
de réir: Mcgready, R, et al.
Foilsithe / Cruthaithe: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
de réir: McGready, R, et al.
Foilsithe / Cruthaithe: (2009)

Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
de réir: Mwesigwa, J, et al.
Foilsithe / Cruthaithe: (2010)

Artemether-lumefantrine coadministration with antiretrovirals; population pharmacokinetics and dosing implications.
de réir: Hoglund, R, et al.
Foilsithe / Cruthaithe: (2014)

The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya.
de réir: Sudoi, R, et al.
Foilsithe / Cruthaithe: (2012)

Quality Assessment of Artemether-Lumefantrine Samples and Artemether Injections Sold in the Cape Coast Metropolis
de réir: James Prah, et al.
Foilsithe / Cruthaithe: (2016-01-01)

Population pharmacokinetics and pharmacodynamics of lumefantrine in young Ugandan children treated with artemether-lumefantrine for uncomplicated malaria
de réir: Tchaparian, E, et al.
Foilsithe / Cruthaithe: (2016)